Kin17在肿瘤中的研究进展

doi:10.11904/j.issn.1002-3070.2023.03.013

Abstract

CLC Number:

R730.2

ZHONG Xuejin, WU Chunmei, LI Qiuyan, ZENG Tao. Research progress of Kin 17 in tumors[J]. Journal of Practical Oncology, 2023, 37(3): 272-275.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2023.03.013

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2023/V37/I3/272

1 Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
2 Biard DS,Miccoli L,Despras E,et al.Lonizing radiation triggers chromatin-bound Kin17 complex formation in human cells[J].J Biol Chem,2002,277(21):19156-19165.
3 Pattaro Júnior JR,Caruso íP,de Lima Neto QA,et al.Biophysical characterization and molecular phylogeny of human kin protein[J].European Biophysics Journal,2019,48(7):645-657.
4 Mazin A,Milot E,Devoret R,et al.Kin17,a mouse nuclear protein,binds to bent DNA fragments that are found at illegitimate recombination junctions in mammalian cells[J].Mol Gen Genet,1994,244:435-438.
5 Carlier L,Couprie J,le Maire A,et al.Solution structure of the region 51-160 of human Kin17 reveals an atypical winged helix domain[J].Protein Sci,2007,16(12):2750-2755.
6 Kannouche P,Mauffrey P,Pinon-Lataillade G,et al.Molecular cloning and characterization of the human Kin17 cDNA encoding a component of the UVC response that is conserve damongment azoans[J].Carcinogenesis,2000,21:1701-1710.
7 le Maire A,Schiltz M,Stura EA,et al.A tandem of sh3-like domains participates in rna binding in Kin17,a human protein activated in response to genotoxics[J].J Mol Biol,2006,364(4):764-776.
8 Ramos AC,Gaspar VP,Kelmer SM,et al.The Kin17 protein in murine melanoma cells[J].Int J Mol Sci,2015,16(11):27912-27920.
9 Kannouche P,Pinon Lataillade G,Tissier A,et al.The nuclear concentration of Kin17,a mouse protein that binds to curved DNA,increases during cell proliferation and after UV irradiation[J].Carcinogenesis,1998,19(5):781-789.
10 Tissier A,Kannouche P,Mauffrey P,et al.Molecular cloning and characterization of the mouse Kin17 gene coding for a Zn-finger protein that preferentially recognizes bent DNA[J].Genomics,1996,38(2):238-242.
11 Despras E,Miccoli L,Créminon C,et al.Depletion of Kin17,a human DNA replication protein,increases the radiosensitivity of rko cells[J].Radiation Research,2003,159(6):748-758.
12 Miccoli L,Frouin I,Novac O,et al.The human stress activated protein Kin17 belongs to the multiprotein DNA replication complex and associates in vivowith mammalian replication origins[J].Mol Cell Biol,2005,25(9):3814-3830.
13 Cloutier P,Lavallee-Adam M,Faubert D,et al.Methylation of the DNA/rna-binding protein Kin17 by mettl22 affects its association with chromatin[J].J Proteomics,2014,100:115-124.
14 Willkinson L,Toral G.Understanding breast cancer as a global health concern[J].Br J Radiol,2022,95(1130):20211033.
15 Zeng T,Gao H,Yu P,et al.Up-regulation of Kin17 is essential for proliferation of breast cancer[J].PLoS One,2011,6(9):e25343.
16 Huang Q,Zahid KR,Chen J,et al.Kin17 promotes tumor metastasis by activating EMT signaling in luminal-A breast cancer[J].Thorac Cancer,2021,12(13):2013-2023.
17 Qiu J,Xue X,Hu C,et al.Comparison of clinicopathological features and prognosis in triple-negative and non-triple negative breast cancer[J].J Cancer,2016,7(2):167-173.
18 Gao X,Liu Z,Zhong M,et al.Knockdown of DNA/RNA-binding protein Kin17 promotes apoptosis of triple-negative breast cancer cells[J].Oncology Letters,2018,17:288-293.
19 Zhang Y,Gao H,Gao X,et al.Elevated expression of Kin17 in cervical cancer and its association with cancer cell proliferation and invasion[J].Int J Gynecol Cancer,2017,27(4):628-633.
20 Uxa S,Castillo P,Kohler R,et al.Ki-67 gene expression[J].Cell DeathDiffer,2021,28(12):3357-3370.
21 Zhong M,Liu Z,Wu K,et al.Kin17 knockdown suppresses the migration and invasion of cervical cancer cells through NF-κB-Snail pathway[J].Int J Clin Exp Pathol,2020,13(3):607-615.
22 Su B,Zhong M,Zhang Y,et al.Deficiency of Kin17 facilitates apoptosis of cervical cancer cells by modulating caspase 3,PARP,and Bcl-2 family proteins[J].J Oncol,2022,2022:3156968.
23 Marques LS,Violin VGA,Meireles LEF,et al.Kin17 high expression as a potential biomarker for high-grade cervical intraepithelial neoplasia[J].Int J Gynaecol Obstet,2023,160:339-341.
24 Kou WZ,Xu SL,Wang Y,et al.Expression of Kin17 promotes the proliferation of hepatocellular carcinoma cells in vitro and in vivo[J].Oncol Lett,2014,8:1190-1194.
25 Dai Z,Huang Q,Huang X,et al.Kin17 promotes cell migration and invasion through stimulating the TGF-β/Smad2 pathway in hepatocellular Carcinoma[J].Mol Carcinog,2023,62:369-384.
26 Yang J,Zhang Y,Sun X,et al.The prognostic value of multiorgan metastases in patients with non-small cell lung cancer and its variants:a SEER-based study[J].J Cancer Res Clin Oncol,2018,144(9):1835-1842.
27 曾涛,陆光明.Kin17在28例肺癌标本中的表达分析[J].检验医学与临床,2013,10(12):1619-1620.
28 Zhang Y,Huang S,Gao H,et al.Upregulation of Kin17 is associated with non-small cell lung cancer invasiveness[J].Oncol Lett,2017,13:2274-2280.
29 吕俊宏,彭盘俐,韦文姜,等.Kin17 在非小细胞肺癌侵袭转移中的作用及机制研究[J].现代生物医学进展,2020,20(15):2838-2842.
30 Chen J,Xia Y,Peng Y,et al.Analysis of the association between Kin17 expression and the clinical features/prognosis of epithelial ovarian cancer,and the effects of Kin17 in SKOV3 cells[J].Oncol Lett,2021,21:475.
31 Jiang QG,Xiong CF,Lv YX.Kin17 facilitates thyroid cancer cell proliferation,migration,and invasion by activating p38 MAPK signaling Pathway[J].Mol Cell Biochem,2021,476:727-739.
32 Ruan L,Jiang Q,Zhang H.Relationships of Kin17 protein expression with clinical features and prognosis of colorectal cancer[J].Transl Cancer Res,2018,7(4):1072-1078.

[1]	ZHOU Borong, SONG Yanan, XIA Wei. Research progress on the role and mechanism of pyrrolin-5-carboxylate reductase-1 in tumor [J]. Journal of Practical Oncology, 2023, 37(3): 267-271.
[2]	YIN Dingwei, JING Jie. Research progress on the role of Gut microbiota in hepatocellular carcinoma and its therapeutic application [J]. Journal of Practical Oncology, 2023, 37(3): 281-286.
[3]	LIU Xinxin, MA Xiyuan, MIU Meiqi, WANG Yuqing, CHEN Jing. Research progress on the role of IL-6 and its receptor in the treatment of breast cancer [J]. Journal of Practical Oncology, 2023, 37(2): 149-154.
[4]	YANG Jianhua, LUO Saimei, LONG Xintian, LI Wei, YANG Birong, YU Longtao, ZHANG Teng, WEN Hongmei. Analyses of incidence and mortality of malignant tumors in cancer registration areas of Yunnan province in 2017 [J]. Journal of Practical Oncology, 2023, 37(1): 6-10.
[5]	MA Jixiong, MA Juhong, ZHUO Hong, LU Zhaoxia, DING Gaoheng, LIU Yuqin. Incidence and mortality of malignant tumors of Baiyin in Gansu province,2018 [J]. Journal of Practical Oncology, 2023, 37(1): 11-16.
[6]	CAI Qirui, YU Xiaolan, LIU Jiaren. Research progress on antitumor activity and other biological effects of geraniol [J]. Journal of Practical Oncology, 2023, 37(1): 58-62.
[7]	LI Shuzhen, CAI Zhifu, RONG Yan, PANG Yebin, LUO Dongni, GAO Kun. Research progress of tumor volume in cervical cancer brachytherapy [J]. Journal of Practical Oncology, 2023, 37(1): 63-67.
[8]	ZHU Xing, ZHANG Bing, ZHAO Jing, JI Hong. Research progress on the role and mechanism of ferroptosis in urinary neoplasms [J]. Journal of Practical Oncology, 2023, 37(1): 73-78.
[9]	CAO Wenjie, WEI Yuan, KUANG Dongming. Tumor infiltrating B cells and immunotherapies [J]. Journal of Practical Oncology, 2022, 36(6): 507-512.
[10]	ZHANG Yue, WANG Yue, WEI Jia. The value of SHP2 as an anti-tumor therapeutic target and its application in tumor immunotherapy [J]. Journal of Practical Oncology, 2022, 36(6): 513-519.
[11]	NA Ruisi, GUO Ying, SHI Jiaqi, ZHENG Tongsen. Reasons why small intestinal tunors are rare [J]. Journal of Practical Oncology, 2022, 36(6): 526-530.
[12]	WANG Xinyi, LU Yiping, SUN Zhengrong. Research progress on the effects of m6A RNA methylation modification on the biological characteristics of malignant tumors and tumor stem cells [J]. Journal of Practical Oncology, 2022, 36(6): 551-555.
[13]	ZHANG Shumin, ZHANG Gong. Research progress of ILC2s in tumor immune regulation [J]. Journal of Practical Oncology, 2022, 36(6): 566-569.
[14]	ZHU Kaibin, HE Changjun, CHEN Lantao, KONG Xianglong, ZHAO Su, XU Shidong. Tumor-associated macrophages promotes non-small cell lung cancer growth and tumor vascularization via PLGF/Flt-1 and TGF-β1 signal pathway [J]. Journal of Practical Oncology, 2022, 36(5): 391-397.
[15]	WANG Qin, LIU Junjie, LU Xiuxin, WU Yafei, ZHANG Wenhao. Research progress of nanocombination therapy based on ferroptosis in the treatment of malignant tumors [J]. Journal of Practical Oncology, 2022, 36(5): 429-434.

Research progress of Kin 17 in tumors

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments